GlassScriptPhysician profile
Brian K Bracy
NPI 1770798878
$3,580.60
in general payments reported to CMS, 2019-2025
39 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $435 · 2021: $466 · 2022: $481 · 2023: $467 · 2024: $1,074 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,806.01 |
| Education | $145.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $499.64 | 2019-2025 | |
| Novo Nordisk INC | $407.64 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $400.81 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Lilly USA, LLC | $266.81 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Astellas Pharma US INC | $246.93 | 2023-2024 | Veozah |
| Antares Pharma, INC. | $238.44 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Amgen INC. | $161.62 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.61 | 2019-2024 | Xifaxan, Trulance |
| Exact Sciences Corporation | $117.16 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $106.01 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.99 | 2021-2024 | Ofev |
| Phathom Pharmaceuticals, INC. | $87.98 | 2024-2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $81.28 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $72.98 | 2021-2025 | Contrave |
| Astrazeneca Pharmaceuticals LP | $49.46 | 2024-2025 | Breztri, Airsupra |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bracy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.